Nano WG: NCI's Alliance for Nanotechnology in Cancer Program: Phase III and Data Sharing Plans
18 Feb 2016 | Presentations | Contributor(s): Stephanie Morris
Launched in 2004, the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer (Alliance) advanced a number of promising nanotechnologies for the diagnosis, treatment and prevention of cancer in its first ten years. This progress led NCI to announce in September 2015 its continued...
Nanomaterial-Biological Interactions Knowledgebase
21 Jan 2016 | Presentations | Contributor(s): Stacey L Harper
Nano WG January 14, 2016 The NBI Knowledgebase is intended to offer industry, academia, the general public, and regulatory agencies a mechanism to rationally inquire for unbiased interpretation of nanomaterial exposure effects in biological systems. The knowledgebase serves as a repository for...
Data Collection from the Nanotoxicology Literature Using ISA-TAB-Nano
21 Jan 2016 | Presentations | Contributor(s): Richard Liam Marchese Robinson
Nano WG meeting January 21, 2016 This is an updated version of the talk originally delivered at the CompNanoTox2015 conference.  Marchese Robinson, R.; Richarz, A.N.; Cassano, A.; Cronin, M.T.D; Rallo, R. (2015): Data Collection from the Nanotoxicology Literature Using ISA-TAB-Nano. FigShare....
Materials Science Data Management Initiatives at NIST
17 Dec 2015 | Presentations | Contributor(s): Robert J. Hanisch
Nano WG December 17, 2015 •NIST is a national and world resource for fundamental data •Access should be easy and open –With regard to IP and privacy issues •As our nation’s standards organization… –NIST should be a leader in national and...
The Open Scholarship Initiative (OSI)
17 Dec 2015 | Presentations | Contributor(s): Glenn Hampson
Nano WG meeting November 19, 2015. : "What should the future of scholarly publishing look like? How about open access? Who should decide? Can journals become more affordable and accessible? Will journals continue to serve as the primary means of communicating research? Can institutional...
Breast Cancer Crossword
20 Nov 2015 | Teaching Materials | Contributor(s): Katelyn Schifano
This crossword is designed for use in social media as well as patient waiting areas.
Nanomaterial Registry Update
22 Oct 2015 | Presentations | Contributor(s): Karmann Mills, Anthony Hickey, Alexander Tropsha
Nano WG weekly meeting October 22,2015
Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment
18 Aug 2015 | Presentations | Contributor(s): Odemaris Narvaez del Pilar
Breast cancer is one of the leading causes of cancer related deaths and morbidity among women worldwide. Identifying new targets and developing new therapies is very important in order to improve patient outcomes and minimize this health burden. MicroRNAs, a type of non-coding RNA, are potential...
UCSC Biomedical Evidence Graph Demonstration
03 Jun 2015 | Presentations | Contributor(s): Josh Stuart, ellrott
The BMEG demonstration includes the following elements: 1) Organization of crowd-source challenges to develop best-of-breed methods including an overview of current DREAM projects, living benchmarks; 2) Enabling cloud-ready methods for mass compute with examples of recently...
Seven Bridges Cancer Genomics Cloud Pilot TCGA 2015 symposium workshop presentation
23 May 2015 | Presentations | Contributor(s): Deniz Kural
Basic and translational cancer research creates the need to disseminate, manage, and interpret large heterogeneous datasets. The volume and complexity of the data now routinely generated by high-throughput technologies has become too costly for individual laboratories and many research...
Video: Learn how TIES can help manage research resources
16 Jan 2015 | Presentations | Contributor(s): Girish Chavan, Rebecca Crowley
CRAVAT Introduction Video - Cancer Related Analysis of Variants
03 Dec 2014 | Teaching Materials | Contributor(s): Michael C Ryan
This video provides a brief overview of the CRAVAT web service(http://www.cravat.us/). CRAVAT provides annotation and analysis of cancer mutations. CRAVAT is free, very easy to use, and can handle large volumes of mutations.[[Youtube(xovmIy11Bcs)]]Please switch to 1080 resolution and watch...
LBL ICBP50 integrative genomic data
13 Nov 2014 | Downloads | Contributor(s): Joe Gray, Jonathan Bistline
From Joe Gray, Lawrence Berkeley National Laboratory. There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...
Baylor Residual breast cancer
13 Nov 2014 | Downloads | Contributor(s): Creighton C, Lewis M, Chang J, Jonathan Bistline
Residual breast cancers after conventional therapy display mesenchymal as tumor-initiating features. There are four (4) files included in this study: Sample Annotation (combined_sample_annotation.txt) Gene expression data from CD44+/CD24- cells sorted by flow cytometry (GSE7513.gct) Human...
Integrated analysis of breast cancer cell lines reveals unique signaling pathways
16 Sep 2014 | Publications | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman
AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...
caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine
13 Dec 2013 | Publications | Contributor(s): Sharon Gaheen, George W Hinkal, Stephanie A Morris, Michal Lijowski, Mervi Heiskanen, Juli Klemm
The use of nanotechnology in biomedicine involves the engineering of nanomaterials to act as therapeutic carriers, targeting agents and diagnostic imaging devices. The application of nanotechnology in cancer aims to transform early detection, targeted therapeutics and cancer prevention and...